NEJM Interviews
NEJM Interviews
NEJM Group
Insightful conversations with leading experts in the field of health care, medical research, policy, and more from the New England Journal of Medicine (NEJM). Each episode examines the many complexities found at the junction of medicine and society.
NEJM Interview: Matthew Vogel on the emergence of clinical trial prediction markets.
Matthew Vogel is a professor at the Brown University School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. M. Vogel, R. Yaeger, and O.J. Wouters. Clinical Trial Prediction Markets — Information, at What Cost? N Engl J Med 2026;395:1565-1567.
Oct 21
7 min
NEJM Interview: Lena Makaroun on opportunities for clinicians to address firearm-related risks with their older patients.
Lena Makaroun is an assistant professor of medicine at the University of Pittsburgh School of Medicine. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. L.K. Makaroun, T.W. Farrell, and M.E. Betz. Firearm-Related Discussions as an Age-Friendly Intervention. N Engl J Med 2026;395:1461-1463.
Oct 14
13 min
NEJM Interview: Sarah Schmitz on protections for people enrolled in trials of investigational agents for obesity.
Sarah Schmitz is an obesity medicine specialist at Weill Cornell Medicine and an assistant attending physician at New York–Presbyterian Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S.H. Schmitz. Beyond Percentage of Weight Lost — Protecting Participants in Obesity Trials. N Engl J Med 2026;395:1355-1357.
Oct 7
5 min
NEJM Interview: Benjamin Scher on opioid litigation and governance systems for spending related funds.
Benjamin Scher is a lecturer and postdoctoral research associate in the Global Health Program at Princeton University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. B.D. Scher and H.H. Howard. Opioid-Settlement Funds — Lessons from Tobacco. N Engl J Med 2026;395:1249-1251.
Sep 30
8 min
NEJM Interview: Christopher Forrest on declines in the health of U.S. children and the role of communities in reversing those trends.
Christopher Forrest is a professor of pediatrics and the director of the Applied Clinical Research Center at Children’s Hospital of Philadelphia. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. C.B. Forrest and N. Halfon. Declining Child Health in the United States — Addressing the Developmental Ecosystem. N Engl J Med 2026;395:1147-1149.
Sep 23
13 min
NEJM Interview: Dhruv Khullar on concerns about displacement of clinicians by artificial intelligence and counterarguments based on economic theory.
Dhruv Khullar is an associate professor of population health sciences and of medicine at Weill Cornell Medical College. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. D. Khullar. Artificial Intelligence and the Future of the Clinical Workforce. N Engl J Med 2026;395:1041-1043.
Sep 16
9 min
NEJM Interview: Elizabeth Kaplan on changes to the U.S. Preventive Services Task Force and the importance of evidence-based recommendations for preventive services.
Elizabeth Kaplan is a clinical instructor and the director of health care access at the Center for Health Law and Policy Innovation at Harvard Law School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E. Kaplan and C. Shachar. The Future of the USPSTF and Evidence-Based Recommendations. N Engl J Med 2026;395:937-939.
Sep 9
11 min
NEJM Interview: Elizabeth Tobin-Tyler on the legal argument that permitting telehealth access to mifepristone can abet reproductive coercion.
Elizabeth Tobin-Tyler is a professor of health services, policy and practice at the Brown University School of Public Health and of family medicine and medical science at Warren Alpert Medical School of Brown University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E. Tobin-Tyler and G. Chalker. Telehealth Access to Mifepristone — Evaluating Reproductive-Coercion Arguments. N Engl J Med 2026;395:833-835.
Sep 2
11 min
NEJM Interview: Rebecca Haffajee on the rescheduling of medical marijuana products and its potential effect on research.
Rebecca Haffajee is a professor in the Department of Health Policy and Management at the Yale School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. R.L. Haffajee, R.A. Mikos, and Z.D. Cooper. Marijuana Rescheduling — A Game Changer for Research? N Engl J Med 2026;395:729-731.
Aug 19
13 min
NEJM Interview: Eric Schneider on the limitations of pay-for-performance programs and alternative options to support quality improvement.
Eric Schneider is an adjunct professor of health policy and management at the Harvard T.H. Chan School of Public Health and a member of the Journal’s Perspective Advisory Board. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. M. Chernew and E.C. Schneider. Rethinking the Role of Pay for Performance in Federal Health Care Quality Programs. N Engl J Med 2026;395:625-628.
Aug 12
8 min
Load more